Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-09-03

Clinical Trial Update: Probiotics for Birch Pollen Allergy [Phase 1, Phase 2]

View source ↗

Summary

The document notes the completion of Phase 1 and Phase 2 trials evaluating probiotics for birch pollen–related seasonal allergic rhinitis, sponsored by Danisco.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotics

Snippet

Sponsor: Danisco | Conditions: Rhinitis, Allergic, Seasonal | Phase 1, Phase 2 | Status: COMPLETED